By Deena Beasley and Julie Steenhuysen (Reuters) - In approving the first new Alzheimer's drug in nearly 20 years, the U.S. Food and Drug Administrati.
By Deena Beasley and Julie Steenhuysen (Reuters) - In approving the first new Alzheimer's drug in nearly 20 years, the U.S. Food and Drug Administrati.
By Deena Beasley and Julie Steenhuysen (Reuters) - In approving the first new Alzheimer's drug in nearly 20 years, the U.S. Food and Drug Administrati.
By Deena Beasley and Julie Steenhuysen (Reuters) - In approving the first new Alzheimer's drug in nearly 20 years, the U.S. Food and Drug Administrati.
Read more about Eli Lilly memo says firm did not make false statements to FDA on Business Standard. (Reuters) - A week before Eli Lilly disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing